131 related articles for article (PubMed ID: 38798586)
1. Low copy CRISPR-Cas13d mitigates collateral RNA cleavage.
Hart SK; Wessels HH; Méndez-Mancilla A; Müller S; Drabavicius G; Choi O; Sanjana NE
bioRxiv; 2024 May; ():. PubMed ID: 38798586
[TBL] [Abstract][Full Text] [Related]
2. Negative autoregulation mitigates collateral RNase activity of repeat-targeting CRISPR-Cas13d in mammalian cells.
Kelley CP; Haerle MC; Wang ET
Cell Rep; 2022 Aug; 40(7):111226. PubMed ID: 35977479
[TBL] [Abstract][Full Text] [Related]
3. High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects.
Tong H; Huang J; Xiao Q; He B; Dong X; Liu Y; Yang X; Han D; Wang Z; Wang X; Ying W; Zhang R; Wei Y; Xu C; Zhou Y; Li Y; Cai M; Wang Q; Xue M; Li G; Fang K; Zhang H; Yang H
Nat Biotechnol; 2023 Jan; 41(1):108-119. PubMed ID: 35953673
[TBL] [Abstract][Full Text] [Related]
4. Cas13d: A New Molecular Scissor for Transcriptome Engineering.
Gupta R; Ghosh A; Chakravarti R; Singh R; Ravichandiran V; Swarnakar S; Ghosh D
Front Cell Dev Biol; 2022; 10():866800. PubMed ID: 35433685
[TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas13d-Mediated Microbial RNA Knockdown.
Zhang K; Zhang Z; Kang J; Chen J; Liu J; Gao N; Fan L; Zheng P; Wang Y; Sun J
Front Bioeng Biotechnol; 2020; 8():856. PubMed ID: 32850723
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-Cas13d for Gene Knockdown and Engineering of CHO Cells.
Shen CC; Lin MW; Nguyen BKT; Chang CW; Shih JR; Nguyen MTT; Chang YH; Hu YC
ACS Synth Biol; 2020 Oct; 9(10):2808-2818. PubMed ID: 32911927
[TBL] [Abstract][Full Text] [Related]
7. Allele-Specific Suppression of Variant MHC With High-Precision RNA Nuclease CRISPR-Cas13d Prevents Hypertrophic Cardiomyopathy.
Yang P; Lou Y; Geng Z; Guo Z; Wu S; Li Y; Song K; Shi T; Zhang S; Xiong J; Chen AF; Li D; Pu WT; Da L; Zhang Y; Sun K; Zhang B
Circulation; 2024 May; ():. PubMed ID: 38752340
[TBL] [Abstract][Full Text] [Related]
8. The effects of length and sequence of gRNA on Cas13b and Cas13d activity in vitro and in vivo.
Liu Y; Jing P; Zhou Y; Zhang J; Shi J; Zhang M; Yang H; Fei J
Biotechnol J; 2023 Sep; 18(9):e2300002. PubMed ID: 37148478
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas13d-mediated efficient KDM5B mRNA knockdown in porcine somatic cells and parthenogenetic embryos.
Bi D; Yao J; Wang Y; Qin G; Zhang Y; Wang Y; Zhao J
Reproduction; 2021 Jul; 162(2):149-160. PubMed ID: 34096883
[TBL] [Abstract][Full Text] [Related]
10. Deep learning and CRISPR-Cas13d ortholog discovery for optimized RNA targeting.
Wei J; Lotfy P; Faizi K; Baungaard S; Gibson E; Wang E; Slabodkin H; Kinnaman E; Chandrasekaran S; Kitano H; Durrant MG; Duffy CV; Pawluk A; Hsu PD; Konermann S
Cell Syst; 2023 Dec; 14(12):1087-1102.e13. PubMed ID: 38091991
[TBL] [Abstract][Full Text] [Related]
11. Cas13d Is a Compact RNA-Targeting Type VI CRISPR Effector Positively Modulated by a WYL-Domain-Containing Accessory Protein.
Yan WX; Chong S; Zhang H; Makarova KS; Koonin EV; Cheng DR; Scott DA
Mol Cell; 2018 Apr; 70(2):327-339.e5. PubMed ID: 29551514
[TBL] [Abstract][Full Text] [Related]
12. Structural Basis for the RNA-Guided Ribonuclease Activity of CRISPR-Cas13d.
Zhang C; Konermann S; Brideau NJ; Lotfy P; Wu X; Novick SJ; Strutzenberg T; Griffin PR; Hsu PD; Lyumkis D
Cell; 2018 Sep; 175(1):212-223.e17. PubMed ID: 30241607
[TBL] [Abstract][Full Text] [Related]
13. Efficient Inhibition of HIV Using CRISPR/Cas13d Nuclease System.
Nguyen H; Wilson H; Jayakumar S; Kulkarni V; Kulkarni S
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578431
[TBL] [Abstract][Full Text] [Related]
14. Harnessing the CRISPR-Cas13d System for Protein Detection by Dual-Aptamer-Based Transcription Amplification.
Feng ZY; Liu R; Li X; Zhang J
Chemistry; 2023 Feb; 29(10):e202202693. PubMed ID: 36400714
[TBL] [Abstract][Full Text] [Related]
15. Efficient nanoparticle-based CRISPR-Cas13d induced mRNA disruption of an eye pigmentation gene in the white-backed planthopper, Sogatella furcifera.
Ma YF; Zhang MQ; Gong LL; Liu XZ; Long GJ; Guo H; Hull JJ; Dewer Y; He M; He P
Insect Sci; 2023 Dec; 30(6):1552-1564. PubMed ID: 37202920
[TBL] [Abstract][Full Text] [Related]
16. Massively parallel profiling of RNA-targeting CRISPR-Cas13d.
Kuo HC; Prupes J; Chou CW; Finkelstein IJ
Nat Commun; 2024 Jan; 15(1):498. PubMed ID: 38216559
[TBL] [Abstract][Full Text] [Related]
17. Shotgun knockdown of RNA by CRISPR-Cas13d in fission yeast.
Chen Z; Zheng S; Fu C
J Cell Sci; 2023 Mar; 136(6):. PubMed ID: 36825467
[TBL] [Abstract][Full Text] [Related]
18. Modeling CRISPR-Cas13d on-target and off-target effects using machine learning approaches.
Cheng X; Li Z; Shan R; Li Z; Wang S; Zhao W; Zhang H; Chao L; Peng J; Fei T; Li W
Nat Commun; 2023 Feb; 14(1):752. PubMed ID: 36765063
[TBL] [Abstract][Full Text] [Related]
19. Insights Gained from RNA Editing Targeted by the CRISPR-Cas13 Family.
Liu L; Pei DS
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232699
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas13 effectors have differing extents of off-target effects that limit their utility in eukaryotic cells.
Ai Y; Liang D; Wilusz JE
Nucleic Acids Res; 2022 Jun; 50(11):e65. PubMed ID: 35244715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
